Gilead Sciences, Inc. (GILD) Q2 2026 Earnings Call Transcript

SA Transcripts 161.48K Followers Follow Gilead Sciences, Inc. ( GILD ) Q2 2026 Earnings Call August 4, 2026 4:30 PM EDT Company Participants Jacquie Ross - Senior Vice President of Treasury & Investor Relations Daniel O'Day - Chairman & CEO Johanna Mercier - Chief Commercial & Corporate Affairs Officer Dietmar Berger - Chief Medical Officer Andrew Dickinson - Executive VP & CFO Cindy Perettie - Executive Vice President of Kite Conference Call Participants Tyler Van Buren - TD Cowen, Research Division Evan Seigerman - BMO Capital Markets Equity Research Michael Yee - UBS Investment Bank, Research Division Geoffrey Meacham - Citigroup Inc., Research Division Brian Abrahams - RBC Capital Markets, Research Division Courtney Breen - Bernstein Institutional Services LLC, Research Division Simon Baker - Rothschild & Co Redburn, Research Division Tazeen Ahmad - BofA Securities, Research Division Anish Nikhanj - Truist Securities, Inc., Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Terence Flynn - Morgan Stanley, Research Division Matthew Dellatorre - Goldman Sachs Group, Inc., Research Division Presentation Operator Good afternoon, everyone, and welcome to Gilead's Second Quarter 2026 Earnings Conference Call. My name is Rebecca, and I'll be today's host. In a moment, we'll begin our prepared remarks followed by our Q&A session. [Operator Instructions] Now I'll hand the call over to Jacquie Ross, Senior Vice President, Treasurer and Head of Investor Relations. Jacquie Ross Senior Vice President of Treasury & Investor Relations Thank you, Rebecca. Just after market closed today, we issued a press release with earnings results for the second quarter of 2026. The press release, slides and supplementary data are available on the Investors section of our website at gilead.com. The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel O'Day; our Chief Commercial and Corporate Affairs Officer, Johanna Mercier; our Chief Medical Officer, Dietmar Berger; and our Chief Financial Officer, Andrew Dickinson. After that, we'll open the call to Q&A, where the team will be joined by Cindy Perettie, the Executive Vice President of Kite.